Explore relationships

Lykos Therapeutics

Resilient Pharmaceuticals, formerly known as Lykos Therapeutics and before that as the MAPS Public Benefit Corporation (MAPS PBC), is a public benefit corporation (PBC) developing MDMA ("ecstasy") for potential medicinal use.

Use + to expand a branch. Click a topic name to open its summary.